Moneycontrol
HomeNewsBusinessReal EstateInvesting in real estate back home – what’s in it for the non-resident Indian?
Trending Topics

Investing in real estate back home – what’s in it for the non-resident Indian?

The impact of lockdowns globally, created Covid distress and raised the significance of investing in Indian real estate simply on grounds of safety, security and stability amidst the globally challenged scenario.

July 04, 2021 / 11:23 IST
Story continues below Advertisement
Hiranandani

From a wealth-creation perspective, the Covid-19 pandemic and the resultant economic impact across global economies has created opportunities in the real estate sector which make sense for an expatriate Indian to evaluate.

Indian real estate has traditionally been a favourite option for the global Indian, and in the post-Covid-19 world, it is even more so – and with good reason. The sentimental aspect is about it being ‘a home, back home’; from an investment perspective, it translates into capital value appreciation along with steady flow of rental income.

Story continues below Advertisement

The Indian growth cogwheel is poised for high gear as the economy witnesses gradual recovery with positive GDP outlook, pent up demand and consumption in festive tailwinds, fiscal stimulus, booster dose by the government and accommodative stance of regulatory bodies to maintain low home loan interest rates, sectoral momentum on full-resumption, accelerated vaccination drive, augmented public spending on infrastructure built up.

These factors account for cumulative growth of Indian real estate as it ranks third among the 14 major sectors in terms of direct, indirect and induced effects in all sectors of the economy. Indian real estate accounts for nearly 7% of GDP growth and 15% of total employment. Hence, growth of real estate is imperative for the economy's buoyant growth.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show